A detailed history of Jcic Asset Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jcic Asset Management Inc. holds 340 shares of BMY stock, worth $16,996. This represents 0.01% of its overall portfolio holdings.

Number of Shares
340
Previous 340 -0.0%
Holding current value
$16,996
Previous $18,000 22.22%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$48.48 - $57.85 $29,087 - $34,710
-600 Reduced 63.83%
340 $17,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $102 - $60,626
-789 Reduced 45.63%
940 $73,000
Q1 2022

Apr 12, 2022

BUY
$61.48 - $73.72 $36,888 - $44,232
600 Added 53.14%
1,729 $126,000
Q4 2021

Jan 19, 2022

SELL
$53.63 - $62.52 $39,149 - $45,639
-730 Reduced 39.27%
1,129 $70,000
Q1 2021

Apr 14, 2021

BUY
$59.34 - $66.74 $20,175 - $22,691
340 Added 22.38%
1,859 $117,000
Q4 2020

Feb 23, 2021

BUY
$57.74 - $65.43 $45,556 - $51,624
789 Added 108.08%
1,519 $94,000
Q3 2020

Oct 08, 2020

BUY
$57.43 - $63.64 $6,317 - $7,000
110 Added 17.74%
730 $44,000
Q2 2020

Aug 07, 2020

BUY
$54.82 - $64.09 $9,319 - $10,895
170 Added 37.78%
620 $36,000
Q1 2020

Apr 17, 2020

BUY
$46.4 - $67.43 $20,880 - $30,343
450 New
450 $25,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $106B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jcic Asset Management Inc. Portfolio

Follow Jcic Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jcic Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jcic Asset Management Inc. with notifications on news.